Lifevantage Net Profit Margin 2010-2024 | LFVN

Lifevantage net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Lifevantage Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-03-31 $0.21B $0.00B 1.95%
2023-12-31 $0.21B $0.00B 1.42%
2023-09-30 $0.21B $0.00B 1.41%
2023-06-30 $0.21B $0.00B 1.40%
2023-03-31 $0.21B 0 0.00%
2022-12-31 $0.21B 0 0.00%
2022-09-30 $0.21B $0.00B 0.49%
2022-06-30 $0.21B $0.00B 1.46%
2022-03-31 $0.21B $0.01B 4.29%
2021-12-31 $0.21B $0.01B 4.72%
2021-09-30 $0.22B $0.01B 6.39%
2021-06-30 $0.22B $0.01B 5.88%
2021-03-31 $0.23B $0.01B 5.33%
2020-12-31 $0.23B $0.01B 5.24%
2020-09-30 $0.23B $0.01B 5.19%
2020-06-30 $0.23B $0.01B 5.17%
2020-03-31 $0.23B $0.01B 5.24%
2019-12-31 $0.23B $0.01B 5.24%
2019-09-30 $0.23B $0.01B 3.98%
2019-06-30 $0.23B $0.01B 3.54%
2019-03-31 $0.22B $0.01B 3.13%
2018-12-31 $0.22B $0.01B 3.20%
2018-09-30 $0.21B $0.01B 2.86%
2018-06-30 $0.20B $0.01B 2.96%
2018-03-31 $0.20B $0.00B 1.50%
2017-12-31 $0.19B $0.00B 0.52%
2017-09-30 $0.19B $0.00B 0.52%
2017-06-30 $0.20B $0.00B 0.50%
2017-03-31 $0.20B $0.00B 1.49%
2016-12-31 $0.21B $0.00B 1.88%
2016-09-30 $0.22B $0.01B 2.78%
2016-06-30 $0.21B $0.01B 2.91%
2016-03-31 $0.20B $0.00B 2.02%
2015-12-31 $0.19B $0.00B 2.14%
2015-09-30 $0.18B $0.00B 1.64%
2015-06-30 $0.19B $0.01B 3.68%
2015-03-31 $0.20B $0.01B 4.48%
2014-12-31 $0.21B $0.01B 4.74%
2014-09-30 $0.22B $0.01B 5.58%
2014-06-30 $0.21B $0.01B 4.67%
2014-03-31 $0.21B $0.01B 3.81%
2013-12-31 $0.21B $0.01B 4.39%
2013-09-30 $0.21B $0.01B 2.91%
2013-06-30 $0.21B $0.01B 3.37%
2013-03-31 $0.20B $0.01B 5.97%
2012-12-31 $0.19B $0.00B 2.14%
2012-09-30 $0.16B $0.01B 8.18%
2012-06-30 $0.13B $0.01B 10.32%
2012-03-31 $0.10B $-0.04B -40.63%
2011-12-31 $0.07B $-0.04B -62.86%
2011-09-30 $0.05B $-0.05B -92.31%
2011-06-30 $0.04B $-0.05B -134.21%
2011-03-31 $0.03B $-0.01B -33.33%
2010-12-31 $0.02B $-0.01B -35.00%
2010-09-30 $0.02B $-0.01B -86.67%
2010-06-30 $0.01B $-0.01B -118.18%
2010-03-31 $0.01B $-0.01B -144.44%
2009-12-31 $0.01B $-0.01B -114.29%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.096B $0.213B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
West Pharmaceutical Services (WST) United States $24.159B 43.30
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00